Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zynerba Pharmaceuticals, Inc.

Clinical trials sponsored by Zynerba Pharmaceuticals, Inc., explained in plain language.

Now part of Harmony Biosciences Holdings, Inc. HRMY NASDAQ

Pharmaceutical company developing cannabinoid-based therapies for neurological disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

CBD gel tested for Long-Term safety in fragile x kids and young adults

Disease control Ongoing

This study looks at the long-term safety of a CBD gel (ZYN002) applied to the skin for children, teens, and young adults with Fragile X syndrome. Participants from two earlier studies will use the gel twice daily for 52 weeks. The main goal is to check for side effects, with a se…

Phase: PHASE2, PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC